Results 241 to 250 of about 1,082,361 (305)
Aims Since their emergence on the drug market, synthetic cannabinoids (SC) are still gaining increasing importance in forensic toxicology. The representatives of the so‐called new psychoactive substances have in common that they have not undergone preclinical safety studies. Hence, knowledge on toxicokinetic (TK) data is sparse.
Adrian A. Doerr +10 more
wiley +1 more source
Edema related to treatment with psychotropic drugs. [PDF]
Engel J +11 more
europepmc +1 more source
Safety pharmacology of acute mescaline administration in healthy participants
Aims Psychedelics, including mescaline, may serve as novel treatments for depression and anxiety. However, data is scarce on the safety of mescaline. Methods The present pooled analysis included two double‐blind, randomized, placebo‐controlled studies with a total of 48 participants and 96 mescaline administrations. Single oral‐dose administrations (n =
Aaron Klaiber +4 more
wiley +1 more source
Psychotropic Drugs for Older Adults With Psychiatric Disorders Presenting to the Emergency Department: Prescription Patterns and Treatment Outcomes. [PDF]
Mazza M +18 more
europepmc +1 more source
Determination of Cortisol Levels in a Small Volume of Saliva of COVID-19-Recovering Patients During Treatment with Psychotropic Drugs. [PDF]
Dziurkowska E +2 more
europepmc +1 more source
Sociodemographic and geographical variation in prescribing psychotropic drugs to children and young people with common mental disorders and Attention Deficit Hyperactive Disorders in North West London: population-based study. [PDF]
Lazzarino AI +8 more
europepmc +1 more source

